Stephens Consulting’s Abiomed Inc ABMD Stock Holding History

Stephens Consulting’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10	Closed	-$2.46K	–	568
2022 Q3	$2.46K	Hold	10	–	–	﹤0.01%	474
2022 Q2	$2.48K	Hold	10	–	–	﹤0.01%	465
2022 Q1	$3.31K	Hold	10	–	–	﹤0.01%	474
2021 Q4	$3.59K	Buy	+10	New	+$3.38K	﹤0.01%	544

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Stephens Consulting's ABMD Position: Q4 2022 in Review

Stephens Consulting sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 10 shares — an estimated $2.46K sold.

Stephens Consulting first reported a position in ABMD in Q4 2021 and held it in 4 quarters. The position peaked at $3.59K in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Stephens Consulting reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Stephens Consulting sold 10 Abiomed Inc shares in Q4 2022, an estimated $2.46K.
Stephens Consulting first reported a position in Abiomed Inc in Q4 2021 and held it in 4 quarters.
Stephens Consulting's Abiomed Inc position peaked at $3.59K in Q4 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Stephens Consulting's 13F filing for Q4 2022, filed 20 Jan 2023.